Search

Sharon X. Wen

Examiner (ID: 11379, Phone: (571)270-3064 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1609, 1644, 1641
Total Applications
952
Issued Applications
502
Pending Applications
90
Abandoned Applications
383

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19473880 [patent_doc_number] => 12103956 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Suicide module compositions and methods [patent_app_type] => utility [patent_app_number] => 17/270827 [patent_app_country] => US [patent_app_date] => 2019-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18734 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270827 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/270827
Suicide module compositions and methods Sep 29, 2019 Issued
Array ( [id] => 15993523 [patent_doc_number] => 20200172632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES [patent_app_type] => utility [patent_app_number] => 16/585805 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585805 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/585805
INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES Sep 26, 2019 Abandoned
Array ( [id] => 15678393 [patent_doc_number] => 20200093860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => ANTIGEN BINDING RECEPTORS [patent_app_type] => utility [patent_app_number] => 16/576546 [patent_app_country] => US [patent_app_date] => 2019-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58852 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576546 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/576546
Antigen binding receptors specific for mutated Fc domains Sep 18, 2019 Issued
Array ( [id] => 15866335 [patent_doc_number] => 20200140571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES [patent_app_type] => utility [patent_app_number] => 16/570591 [patent_app_country] => US [patent_app_date] => 2019-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570591 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/570591
INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES Sep 12, 2019 Abandoned
Array ( [id] => 17875571 [patent_doc_number] => 11447572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Anti-ceramide antibodies [patent_app_type] => utility [patent_app_number] => 16/568152 [patent_app_country] => US [patent_app_date] => 2019-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 11832 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16568152 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/568152
Anti-ceramide antibodies Sep 10, 2019 Issued
Array ( [id] => 15296029 [patent_doc_number] => 20190391150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES [patent_app_type] => utility [patent_app_number] => 16/566273 [patent_app_country] => US [patent_app_date] => 2019-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566273 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/566273
COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES Sep 9, 2019 Abandoned
Array ( [id] => 18434464 [patent_doc_number] => 20230181758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/271176 [patent_app_country] => US [patent_app_date] => 2019-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271176 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/271176
EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF Aug 22, 2019 Abandoned
Array ( [id] => 15915421 [patent_doc_number] => 10654940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-19 [patent_title] => Method for treating joint damage [patent_app_type] => utility [patent_app_number] => 16/526727 [patent_app_country] => US [patent_app_date] => 2019-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 49 [patent_no_of_words] => 51468 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526727 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/526727
Method for treating joint damage Jul 29, 2019 Issued
16/475876 Biomarkers For Detecting Human Glycogen Phosphorylase Isoenzyme BB Jul 2, 2019 Abandoned
Array ( [id] => 15363675 [patent_doc_number] => 20200017602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => PLASMA KALLIKREIN BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 16/445304 [patent_app_country] => US [patent_app_date] => 2019-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70762 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445304 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/445304
Nucleic acids encoding plasma kallikrein binding proteins Jun 18, 2019 Issued
Array ( [id] => 16779367 [patent_doc_number] => 20210116445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => METHOD FOR SEPARATING ANTIBODY, AND METHOD FOR TESTING ON DISEASE [patent_app_type] => utility [patent_app_number] => 17/253824 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253824 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253824
Method for separating antibody, and method for testing on disease Jun 17, 2019 Issued
Array ( [id] => 15408085 [patent_doc_number] => 20200024364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/415837 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415837 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/415837
DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS May 16, 2019 Abandoned
Array ( [id] => 18013338 [patent_doc_number] => 11505620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Methods of detecting plasma kallikrein [patent_app_type] => utility [patent_app_number] => 16/411242 [patent_app_country] => US [patent_app_date] => 2019-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 67842 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1572 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411242 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/411242
Methods of detecting plasma kallikrein May 13, 2019 Issued
Array ( [id] => 16500006 [patent_doc_number] => 10865382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Reducing immune tolerance induced by PD-L1 [patent_app_type] => utility [patent_app_number] => 16/404349 [patent_app_country] => US [patent_app_date] => 2019-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13859 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404349 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/404349
Reducing immune tolerance induced by PD-L1 May 5, 2019 Issued
Array ( [id] => 17206660 [patent_doc_number] => 11167011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-09 [patent_title] => Methods for treating bone loss using sclerostin peptides [patent_app_type] => utility [patent_app_number] => 16/396896 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20607 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396896 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/396896
Methods for treating bone loss using sclerostin peptides Apr 28, 2019 Issued
Array ( [id] => 15008527 [patent_doc_number] => 10450379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-22 [patent_title] => Method for treating joint damage [patent_app_type] => utility [patent_app_number] => 16/384333 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 49 [patent_no_of_words] => 51518 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384333 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/384333
Method for treating joint damage Apr 14, 2019 Issued
Array ( [id] => 15038733 [patent_doc_number] => 20190330371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations [patent_app_type] => utility [patent_app_number] => 16/367795 [patent_app_country] => US [patent_app_date] => 2019-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16000 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367795 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/367795
Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations Mar 27, 2019 Abandoned
Array ( [id] => 15206403 [patent_doc_number] => 20190365888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS [patent_app_type] => utility [patent_app_number] => 16/363836 [patent_app_country] => US [patent_app_date] => 2019-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363836 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/363836
COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS Mar 24, 2019 Abandoned
Array ( [id] => 15408089 [patent_doc_number] => 20200024366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING [patent_app_type] => utility [patent_app_number] => 16/296852 [patent_app_country] => US [patent_app_date] => 2019-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16296852 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/296852
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING Mar 7, 2019 Abandoned
Array ( [id] => 15293665 [patent_doc_number] => 20190389968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => ANTI-PCSK9 ANTIBODIES AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/294085 [patent_app_country] => US [patent_app_date] => 2019-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 147424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294085 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/294085
ANTI-PCSK9 ANTIBODIES AND USE THEREOF Mar 5, 2019 Abandoned
Menu